Seamus Kent is a researcher in HERC with research interests in obesity, chronic disease, economic modelling, and the use of large cohort and linked electronic health record data.
Seamus joined the Nuffield Department of Population Health in 2012 to develop health economics research using data from two large contemporary clinical trials, HPS2-THRIVE and SHARP. His research focused on estimating the impacts of adverse events, demographic characteristics and common risk factors on healthcare costs and health-related quality of life in populations at increased cardiovascular disease risk, and, in the case of SHARP, a population with chronic kidney disease.
In 2014 Seamus was awarded an NIHR Doctoral Research Fellowship to study the impact of overweight and obesity on long-term health and healthcare resource use and costs using the Million Women Study and linked administrative data. He successfully defended his Thesis in January 2018.
Since completing his DPhil, Seamus has been undertaking a model based economic evaluation of doctor referral to a total diet replacement programme in the DROPLET Study.
Seamus graduated with a BSc in Economics in 2009 and was awarded an MSc in Health Economics at the University of York in 2010 and an MSc in Medical Statistics at the University of Leicester in 2013.
Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease
SCHLACKOW I. et al, (2019), Kidney International
Body mass index and use and costs of primary care services among women aged 55 to 79 years in England: a cohort and linked data study
KENT SEAMUS. et al, (2018), International Journal of Obesity
A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
Schlackow I. et al, (2017), Heart
Body mass index and healthcare costs: a systematic literature review of individual participant data studies
Kent S. et al, (2017), Obesity Reviews
Hospital costs in relation to body mass index in 1.1 million women in England: a prospective cohort study
Kent S. et al, (2017), Lancet Public Health